Japanese Aerospace & Defense Stock News

TSE:6200
TSE:6200Professional Services

Global Dividend Stocks To Enhance Your Investment Portfolio

As global markets experience fluctuations, with major indices like the Nasdaq Composite and S&P 500 facing recent declines, investors are increasingly looking toward stable investment options. In such a volatile environment, dividend stocks can offer a reliable income stream and act as a buffer against market turbulence, making them an appealing choice for enhancing investment portfolios.
TSE:8591
TSE:8591Diversified Financial

Is ORIX’s Debt Shelf And Upgraded Earnings Outlook Altering The Investment Case For ORIX (TSE:8591)?

In July 2026, ORIX Corporation filed a shelf registration for debt securities while analysts reported very large upward revisions to its current-year earnings estimates and assigned it a top Zacks Rank, supported by favorable value and momentum scores. This combination of new financing flexibility and improving analyst assessments has sharpened investor focus on ORIX’s earnings outlook and relative valuation. Next, we’ll examine how these sharply higher earnings estimates and strong value...
TSE:2502
TSE:2502Beverage

What Asahi Group Holdings (TSE:2502)'s Higher Planned Year-End Dividend Means For Shareholders

Earlier in July 2026, Asahi Group Holdings issued 2026 guidance, projecting sales of ¥3.22 trillion, operating profit of ¥297.00 billion and profit attributable to owners of parent of ¥194.00 billion, alongside expected basic earnings of ¥129.71 per share. The company also signaled a stronger shareholder return stance by guiding for a higher year-end dividend of ¥31.00 per share, compared with ¥26.00 per share previously. Against this backdrop, we’ll explore how Asahi’s higher planned...
TSE:5016
TSE:5016Metals and Mining

3 Japanese Value Stocks With Strong Earnings Growth Trading Below Fair Value

Global markets are being pulled around by inflation worries, higher energy costs and shifting central bank policies, which can make broad index investing feel uncomfortable. In this kind of climate, investors often look for high quality undervalued stocks that combine solid cash generation with resilient balance sheets. That is exactly what this High Quality Undervalued Stocks screener aims to highlight, flagging companies that the market may be overlooking. In this article, you will see...
TSE:3048
TSE:3048Specialty Retail

Is Bic Camera (TSE:3048) Undervalued Following Its VARREL Esports Sponsorship?

Bic Camera (TSE:3048) has entered a sponsorship agreement with Japanese esports organization VARREL, linking the retailer’s brand to competitive gaming events, fan activities, and broadcasts across Japan’s esports scene. See our latest analysis for Bic Camera. At a share price of ¥1,715.5, Bic Camera has shown modest short term momentum, with a 7 day share price return of 4.41%, while its 1 year total shareholder return of 9.47% reflects stronger longer term compounding from price moves and...
TSE:9697
TSE:9697Entertainment

Asian Growth Companies With High Insider Ownership To Watch

Amid a backdrop of volatility in global markets, Asian equities have shown resilience, with certain sectors experiencing notable growth despite broader economic challenges. In this environment, companies with high insider ownership often stand out as potential opportunities due to the alignment of interests between management and shareholders.
TSE:3282
TSE:3282Residential REITs

How Investors May Respond To Comforia Residential REIT (TSE:3282) Acquisition-Fueled Equity Raise And Earnings Upgrade

Earlier this month, Comforia Residential REIT announced the acquisition of five domestic residential assets, the issuance of 107,620 new investment units via a follow-on equity offering, and an upward revision to its operating and profit forecasts for the period ending January 31, 2027. An interesting aspect of the announcement is how the asset acquisitions and equity issuance are directly tied to updated earnings assumptions based on current rental residence market conditions. Next, we will...
TSE:7733
TSE:7733Medical Equipment

How Olympus’ New Chief Quality Officer Appointment At Olympus (TSE:7733) Has Changed Its Investment Story

Olympus Corporation has appointed Brian Barry as Executive Officer and Chief Quality Officer, succeeding Boris Shkolnik, following a Board resolution effective August 1, 2026, marking a leadership transition in the company’s global quality and regulatory function. This move brings in a leader with more than 40 years of experience across global Quality, Regulatory Affairs, Medical Safety, and Clinical Affairs, underlining Olympus’s focus on strengthening quality systems, patient safety, and...
TSE:8267
TSE:8267Consumer Retailing

Will Aeon’s (TSE:8267) Q1 2027 Return To Profitability Reshape Its Investment Narrative?

Aeon Co., Ltd. reported Q1 2027 results on July 10, 2026, with sales of ¥2,702,257 million, revenue of ¥2,941,981 million, and net income of ¥13,809 million, marking a return to profitability versus a loss a year earlier. The swing from a basic loss per share of ¥2.54 to earnings of ¥4.99 from continuing operations highlights a sharp improvement in Aeon’s underlying performance. We’ll now examine how Aeon’s return to profitability and higher revenue in Q1 2027 may reshape its existing...
TSE:3046
TSE:3046Specialty Retail

Asian Stocks That May Be Trading Below Estimated Value In July 2026

In recent weeks, Asian markets have experienced significant volatility, with technology stocks facing downward pressure amid concerns over valuations and geopolitical tensions. Despite these challenges, the region presents opportunities for investors seeking undervalued stocks that may offer potential value based on current market conditions. Identifying such stocks requires a careful analysis of financial health, growth prospects, and market positioning within the broader economic landscape.
TSE:9003
TSE:9003Transportation

Is Sotetsu Holdings (TSE:9003) Undervalued After Its ¥10b Bond Issue?

Sotetsu Holdings (TSE:9003) has drawn fresh attention after setting the terms for its 47th unsecured bond issue, a ¥10.0b, 10 year offering carrying a 3.224% annual coupon and general public placement. See our latest analysis for Sotetsu Holdings. For context, Sotetsu Holdings’ share price has risen 8.07% over the past month but is down 9.37% over the past quarter, while its 1 year total shareholder return of 14.59% points to momentum building over a longer horizon. If this bond issue has you...
TSE:4523
TSE:4523Pharmaceuticals

Does Real‑World Leqembi Iqlik Data And At‑Home Use Shift The Bull Case For Eisai (TSE:4523)?

Eisai and Biogen recently reported real-world data from the three-year LEADER study showing that nearly 83% of early Alzheimer’s patients on Leqembi remained stable or improved over about 17 months, and secured U.S. FDA approval for once-weekly subcutaneous Leqembi Iqlik as an at-home initiation option. These updates suggest that Leqembi’s convenience, persistence on therapy and consistency across diverse patient groups could be increasingly important drivers of its clinical and commercial...
TSE:2337
TSE:2337Real Estate

Ichigo (TSE:2337) Held Its Q1 2027 Earnings Call, Is The Stock A Bargain?

Ichigo Q1 2027 earnings call as a fresh catalyst Ichigo (TSE:2337) recently released its Q1 2027 pre recorded earnings call on July 15, 2026, giving investors fresh information on its real estate, hotel, and clean energy businesses in Japan. See our latest analysis for Ichigo. Ichigo's Q1 2027 earnings update comes after a mixed share price pattern, with the stock up 4.11% over the last day but down 15.98% over 90 days. Meanwhile, 1 year and 3 year total shareholder returns of 17.47% and...
TSE:7459
TSE:7459Healthcare

Is MediPal Holdings (TSE:7459) Still Worth A Look On Higher Dividend Guidance?

MediPal Holdings (TSE:7459) has updated investors with higher full year dividend guidance and revised earnings expectations after completing its tender offer for PALTAC Corporation, which shifts more of PALTAC's profit fully onto its books. See our latest analysis for MediPal Holdings. Recent moves suggest growing interest in MediPal Holdings, with a 1 month share price return of 9.92% and a 1 year total shareholder return of 19.90%. This points to building momentum around the revised...
TSE:3391
TSE:3391Consumer Retailing

Why Tsuruha Holdings’ (TSE:3391) Soaring Sales With Lower EPS May Redefine Its Investment Story

Tsuruha Holdings Inc. previously reported first-quarter 2026 results, with sales rising to ¥636,886 million from ¥272,530 million and net income increasing to ¥13,477 million from ¥11,112 million a year earlier. Despite higher sales and net income, basic earnings per share from continuing operations fell to ¥29.75 from ¥45.66, hinting at changes in share count or profit mix that matter for investors. Next, we examine how this mix of rapid sales expansion and lower earnings per share shapes...
TSE:6367
TSE:6367Building

Carrier Stock And 2 Cooling Shares Tied To Europe’s Heat Wave Spending

Europe’s record heat is turning air conditioning from a luxury into critical infrastructure, and that shift is starting to influence where capital flows. As governments debate funding for cooling in hospitals and schools and push for greener, more efficient systems, some stocks exposed to this climate adaptation story could see fresh attention while others may face tougher questions. This article explores how the news-driven theme around European air conditioning expansion connects to three...
TSE:4523
TSE:4523Pharmaceuticals

Eisai (TSE:4523) Following Leqembi Home Dosing Approval Is The Alzheimer’s Upside Already Priced In

Eisai (TSE:4523) is back in focus after fresh Alzheimer’s data and a new at-home dosing option for Leqembi. These developments together reshape how investors might think about the company’s neurology franchise. See our latest analysis for Eisai. Eisai’s latest Alzheimer’s updates arrive alongside a 12.12% 1 month share price return, though the share price is still down 7.04% year to date, while the 1 year total shareholder return of 16.39% contrasts with weaker 3 and 5 year total shareholder...
TSE:3349
TSE:3349Consumer Retailing

The Bull Case For COSMOS Pharmaceutical (TSE:3349) Could Change Following Dividend Shift And 2027 Guidance

COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026. At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...